Click here to view the 2020 ASCO Industry Showcase.
| | | Sponsored by: CMIC Group Our specialized oncology team, with extensive experience and an established network of KOLs, will support your project with strategic development planning, regulatory interaction, clinical studies and post-marketing promotion for companies entering the field of oncology. Schedule a virtual meeting with us today! |
|
|---|
|
| | | Sponsored by: Natera Featured Signatera ASCO Presentation: Dr. Noelia Tarazona will be presenting a new study evaluating the validity of Signatera ctDNA assay to detect molecular residual disease (MRD) in CRC patients who are at high risk of recurrence, during and after adjuvant chemotherapy. Serial ctDNA analysis detected MRD up to 16.6 months before radiologic imaging. Click here to dive deeper. Not an official event of the 2020 ASCO Annual Meeting. Not sponsored, endorsed, or accredited by ASCO®, CancerLinQ®, or the Conquer Cancer® The ASCO Foundation. |
|
|---|
|
|
|
